Studies on the Antibacterial Activity of Ceftiofur Sodium in Vitro and Birds
Khalid A. Al-Kheraije
Shaqra University, Shaqra, KSA.
DOI: 10.4236/ojvm.2013.31004   PDF   HTML   XML   6,167 Downloads   9,924 Views   Citations


This study was carried out to evaluate the antibacterial activity of ceftiofur sodium as anti-infective chemotherapeutic agent belonged to the third generation of cephalosporins against different bacterial pathogens in vitro and birds. The obtained results showed that it was more effective and superior in its action than that the other compared antibacterial agents. The disc diffusion test revealed that most P. multocida isolates were highly sensitive to ceftiofur sodium with minimum inhibitory concentrations (MICs) ranging between 0.625 - 2.5 μg/ml and minimal bactericidal concentration (MBCs) equal or two folds of the MICs.

Share and Cite:

K. Al-Kheraije, "Studies on the Antibacterial Activity of Ceftiofur Sodium in Vitro and Birds," Open Journal of Veterinary Medicine, Vol. 3 No. 1, 2013, pp. 16-21. doi: 10.4236/ojvm.2013.31004.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] R. E. Hornish and S. F. Kotarski, “Cephalosporions in Veterinary Medicine—Ceftiofur Use in Food Animals,” Current Topics in Medicinal Chemistry, Vol. 2, No. 7, 2002, pp. 717-731. doi:10.2174/1568026023393679
[2] A. E. Abd-Ellateif and I. M. G. El-Din, “The Role of Ceftiofur Sodium (Excenel) in the Control of Pasteurella multocida Infection in Chickens,” Proceeding of the 4th Veterinary Medicine Zagazing Congress, Hurghada, 26- 28 August 1998, pp. 632-645.
[3] A. M. Fayaz, K. Balaji, M. Girilal, R. Yadav, P. T. Kalaichelvan and R. Venketesan, “Biogenic Synthesis of Silver Nanoparticles and Their Synergestic Effect with Antibiotics: A Study against Gram Positive and Gram Negative Bacteria,” Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 6, No. 1, 2010, pp. 103-109. doi:10.1016/j.nano.2009.04.006
[4] R. J. Yancey, M. Kinney, B. Roberts, K. Goodenough, J. Hamel and C. Ford, “Ceftiofur Sodium a Broad Spectrum Cephalosporin: Evaluation in Vitro in Mice,” American Journal of Veterinary Research, Vol. 48, No. 7, 1987, pp. 1050-1053.
[5] X. L. Li, M. Weizhen, L. Michael, Y. Machesk, S. R. Yates and M. Katterhenry, “Degradation Kinetics and Mechanism of Antibiotic Ceftiofur in Recycled Water Derived from a Beef Farm,” Journal of Agricultural and Food Chemistry, Vol. 59, No. 18, 2011, pp. 10176-10181. doi:10.1021/jf202325c
[6] S. A. Brown, P. S. Jaglan and A. Banting, “Ceftiofur Sodium, Disposition, Protein-Binding, Metabolism, Small Residue Depletion Profile in Various Species,” Acta Veterinaria Scandinavica Supplementum, Vol. 86, 1991, p. 99.
[7] S. A. Salmon, J. L. Watts and R. J. Yancey, “In Vitro Activity of Ceftiofur and Its Metabolites Desfuroyl Ceftiofur against Organism of Veterinary Importance,” Journal of Veterinary Diagnostic Investigation, Vol. 8, No. 3, 1996, pp. 332-336. doi:10.1177/104063879600800309
[8] S. Meyer, S. Giguere, R. Rodriguez, R. J. Zielinski, G. S. Grover and S. A. Brown, “Pharmacokinetics of Intravenous Ceftiofur Sodium and Concentration in Body Fluids of Foals,” Journal of Veterinary Pharmacology and Therapeutics, Vol. 32, No. 4, 2009, pp. 309-316. doi:10.1111/j.1365-2885.2008.01041.x
[9] T. L. Hall, L. A. Tell, S. E. Wetzlich, J. D. McCormick, L. W. Fowler and N. Pusteria, “Pharmacokinetics of Ceftiofur Sodium and Ceftiofur Crystalline Free Acids in Neonatal foalsm,” Journal of Veterinary Pharmacology and Therapeutics, Vol. 34, No. 4, 2011, pp. 403-409. doi:10.1111/j.1365-2885.2010.01252.x
[10] E. J. C. Goldstein, D. M. Goldstein, C. V. Merriam and K. L. Tyrrell, “Ceftaroline versus Isolates from Animal Bite Wounds: Comparative in Vitro Activities against 243 Isolates, Including 156 Pasteurellaspecies Isolates,” Antimicrobial Agents and Chemotherapy, Vol. 56, No. 12, 2012, pp. 6319-6323. doi:10.1128/AAC.01794-12
[11] T. R. Schriemer, J. B. Paulissen and K. J. Dame, “Evaluation of Ceftiofur Sodium for Control of Terminal Bacterial Infection in One Day Old Broiler Chickens,” Proceeding of the 19th World Poultry Congress, Ilege, 19-24 September 1992, pp. 11-15.
[12] K. L. Hope, L. A. Tell, B. A. Byrne, S. Murray, S. E. Wetzlich, L. H. Ware, W. Lynch, L. R. Padilla and N. C. Boedeker, “Pharmacokinetics of a Single Intramuscular Injection of Ceftiofur Crystalline—Free Acid in American Black Ducks (Anasrubripes),” American Journal of Veterinary Research, Vol. 73, No. 5, 2012, pp. 620-627. doi:10.2460/ajvr.73.5.620
[13] R. S. Singer, S. K. Patterson and R. L. Wallace, “Effects of Therapeutic Ceftiofur Administration to Dairy Cattle on E. coli Dynamics in the Intestinal Tract,” Applied and Environmental Microbiology, Vol. 74, No. 22, 2008, pp. 6956-6962. doi:10.1128/AEM.01241-08
[14] S. M. Finegold and W. J. Martin, “Diagnostic Microbiology,” 6th Edition, C.V. Mosby Co. St. Louis, Toronto, London, 1982.
[15] J. Gangoue-Pieboji, N. Eze, D. A. Ngongang, B. Ngameni, N. Tsabang, D. E. Pegnyemb, L. Biyiti, P. Ngassam, S. S. Koulla and M. Galleni, “The in-Vitro Antimicrobial Activity of Some Medicinal Plants against Beta Lactam Resistant Bacteria,” Journal of Infection in Developing Countries, Vol. 3, No. 9, 2009, pp. 671-680.
[16] J. G. Choi, O. H. Kang, Y. S. Lee, H. S. Chae, Y. C. Oh, O. O. Brice, M. S. Kim, D. H. Sohn, H. Sookim, H. Park, D. W. Shin, J. R. Rho and D. Y. Kwon, “In Vitro and in Vivo Antibacterial Activity of Punicagranatum Peel Ethanol Extract against Salmonella,” Evidence-Based Complementary and Alternative Medicine, Vol. 211, No. 1, 2011, p. 8.
[17] P. I. Ushimaru, L. N. Barbosa, A. A. H. Fernandes, L. C. Distasi and A. F. Junior, “In Vitro Antibacterial Activity of Medicinal Plant Extracts against Escherichia coli Strains from Human Clinical Specimens and Interactions with Antimicrobial Drugs,” Natural Product Research, Vol. 26, No. 16, 2012, pp. 1553-1557. doi:10.1080/14786419.2011.568943
[18] Anon, National Committee for Clinical Laboratory Standards, “Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically,” 2nd Edition, Document M7A2 (NCCLS), Vol. 10, 1991, pp. 1-13.
[19] L. Dutil, R. Irwin, R. Finley, K. Ngl and B. Avery, “Ceftiofur Resistance in Salmonella entericserovar Heidelbery from Chicken Meat and Humans, Canada,” Emerging Infectious Diseases, Vol. 16, No. 1, 2010, pp. 48-54. doi:10.3201/eid1601.090729
[20] T. G. Hungerford, “A Clinical Rate on Avian Cholera; The Effect of Age on the Susceptibility of Fowls,” Australian Veterinary Journal, Vol. 44, No. 1, 1968, pp. 31- 32. doi:10.1111/j.1751-0813.1968.tb04912.x
[21] W. B. Gross and C. H. Domermuth, “Colibacillosis; In Isolation and Identification of Avian Pathogens,” 2nd Edition, Creative Prin. Co., New York, 1980.
[22] M. Scheer, “Studies on the Antibacterial Activity of Baytril (Enrofloxacin),” Veterinary Medical Review, Vol. 2, No. 1, 1987, pp. 90-99.
[23] D. L. Raemdanek, A. C. Tanner, S. T. Tolling and S. L. Michener, “In Vitro Susceptibility of Avian Escherichia coli and Pasteurella multocida to Danofloxacin and Five Other Antimicrobials,” Avian Diseases, Vol. 36, No. 4, 1992, pp. 694-697.
[24] D. Persons, F. Haesebrouck, A. Smet, L. Herman and M. Heyndrickx, “Risk Factors for Ceftiofur Resistance in Escherichia coli from Belgian Broilers,” Epidemiology and Infection, Vol. 139, No. 5, 2011, pp. 765-771. doi:10.1017/S0950268810001524
[25] A. Franklin, “The in Vitro Bactericidal Activity of Danofloxacin and Ceftiofur against Respiratory Pathogens in Cattle,” Proceedings of the 17th world Buiatrics Congress, Vol. 3, 1992, pp. 214-217.
[26] L. K. Klein, R. J. Yancey, C. A. Case and S. A. Salmon, “Minimum Inhibitory Concentration of Selected Antimicrobial Agents against Bacteria Isolated from 1 - 14 Day Old Broiler Chicks,” Journal of Veterinary Diagnostic Investigation, Vol. 8, No. 4, 1996, pp. 494-495. doi:10.1177/104063879600800418
[27] H. Hariharan, E. Croft, S. Heaney and Y. Bryenton, “Drug Resistance Patterns among Salmonella Isolates,” The Canadian Veterinary Journal, Vol. 34, No. 12, 1993, pp. 45-47.
[28] P. J. Blackall, J. Pahoff, C. P. Stephens and F. M. Darvill, “In Vitro Activity of Ceftiofur against Pasteurella Isolates of the Family Pasteurellacea Associated with Respiratory Disease in Cattle and Pigs. Aust,” The Veterinary Journal, Vol. 74, No. 1, 1996, p. 71.
[29] S. A. Brown, R. J. Yancey and J. Steffan, “Ceftiofur Sodium: Antimicrobial Activity of Parent Ceftiofur and Metabolites,” Acta Veterinaria Scandinavica Supplementum, Vol. 87, No. 1, 1991, p. 95.
[30] F. Alexander, “An Introduction of Vet. Pharm,” 4th Edition, Longman, London, New York, 1985.
[31] W. C. Scheffer, “Statistics for Biological Sciences,” 2nd Edition, Addison Wesley, Reading, 1979.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.